Kumari M, Rathi B, Singh G. Epicatechin as a potential hit to target ERK2 in breast cancer: molecular docking, molecular dynamic simulation studies. J Integr Sci Technol. 2025;13(4):1074. doi:10.62110/sciencein.jist.2025.v13.1074